Laboratory Animal Models, 3D Cultures, and Organoids Market: Overview

Appropriate laboratory animal models are a must for research studies applicable in pharmaceutical and biotechnology industries, academic studies, and advanced research

Several model systems drive biological research by recapitulating body processes and functions from the molecular to whole organism level and bring desired results to the highest possible level

The human body is composed of both cellular and non-cellular materials organized in a highly specialized manner. It is difficult to mimic all aspects of human biology with one in vitro model system. Organoidsare in vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization, and exhibit organ functionality.

Report Overview:

https://www.transparencymarketresearch.com/laboratory-animal-models...

3D cell culture models are a more accurate representation of the natural environment experienced by cells in a living organism as opposed to growing cells on 2D flat surfaces. Based on severity of disease, different types of treatments or therapies are suggested to patients. Organoids, spheroids, and the study of 3D cell culture models show great potential in many applications including disease modeling and regenerative medicine.

All these models are used in drug discovery stage, therapeutic activity evaluation, and discovery for new bacteria or viruses

Key Drivers and Restraints of Global Laboratory Animal Models, 3D Cultures, and Organoids Market

Ongoing research activities and higher demand for 3D models in clinical stages of drug discovery are some of the major factors responsible for the growth of the laboratory animal models, 3D cultures, and organoids market.

Rise in chronic diseases and spread of bacteria and viruses across the world is leading to increase in research & development activities using laboratory animals, 3D cultures, and organoids

For instance, as per the World Health Organization (WHO), currently, dementia affects nearly 10 million people in Europe and is likely to double by 2030

Moreover, alternative approaches for research studies and government funding & initiatives for research activities using different models are also fuelling the growth of the global market

Request For Custom Research:

https://www.transparencymarketresearch.com/sample/sample.php?flag=C...

Strict Regulatory Norms to Hamper Market

Government agencies and different societies are imposing and demanding certain limitation on use of laboratory animal models for research activities in terms of ethical use. This leads the government to impose ban for using certain species of animal models.

These strict regulatory norms in terms of use can hamper the global laboratory animal models, 3D cultures, and organoids market

Certain complications arise in using models for studies. These complications include less resemblance of biological activity with human biological system, ineffective results, and irrational conclusions in research experiments which can restrain the global market.

Laboratory Animal Models Segment Dominated Global Market

Based on product type, global laboratory animal models, 3D cultures, and organoids market is classified into laboratory animal models, 3D cell cultures, and organoids

Laboratory animal models dominated the global market due to higher demand of these models in drug discovery and higher resemblance of some species with human biological models

The organoids segment is likely to be a lucrative segment during the forecast period, owing to advancements in tissue engineering and emerging applications in regenerative medicines

The 3D cell cultures segment is further sub-divided into spheroids, scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, and others

The organoids segment is further sub-segmented into intestinal organoid, neural organoid, pancreatic organoid, and others

Request Brochure:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

Personalized Medicines to be Promising Application Segment

In terms of application, the global laboratory animal models, 3D cultures, and organoids market is divided into drug discovery, cancer research, personalized medicine, regenerative medicines & transplantations, and others

Drug discovery is a major segment in terms of market share, owing to higher cost involved for drug research and higher demand of laboratory animals and 3D models for different studies in drug discovery

The personalized medicines segment is anticipated to be a highly lucrative segment during the forecast period, owing to increase in adoption of personalized medicines in the next few years and growing prevalence of chronic diseases

Life Sciences Companies Accounted for Larger Market Share

On the basis of end-user, the global laboratory animal models, 3D cultures, and organoids market is divided into life sciences companies, academic & research institutes, CROs, and others

The life sciences companies segment is expected to dominate the global market during the forecast period. Rise in research activities for new drug discovery, growing R&D funding by these companies, and higher operational output by these models in research activities are some of the major factors for the growth of this segment.

North America to Lead Global Market

In terms of region, the global laboratory animal models, 3D cultures, and organoids market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America dominated the global laboratory animal models, 3D cultures and organoids market in 2018 due to higher prevalence of chronic diseases in the region, ongoing research activities, and early adoption of advanced products in research activities

Asia Pacific is anticipated to be a promising segment in the next few years as it is likely to have higher number of geriatric population along with rise in chronic disease population, growing research activities, and higher patient pool for clinical studies

Request for TOC:

https://www.transparencymarketresearch.com/sample/sample.php?flag=T...

Key Manufacturers Operating in Global Market

Key manufacturers operating in the global market include:

Charles River Laboratories International Inc.
Merck KGaA, Darmstadt
Thermo Fisher Scientific Inc.
Alpha Genesis Incorporated
Covance Inc.
BIOINK SOLUTION, INC.
3Dnamics Inc.
Emulate, Inc.
Crown Bioscience Inc.  
Envigo

Global Laboratory Animal Models, 3D Cultures, and Organoids Market: Research Scope

Global Laboratory Animal Models, 3D Cultures, and Organoids Market, by Product Type

Laboratory Animal Models
3D Cell Cultures
Spheroids
Scaffold-based 3D Cell Cultures
Scaffold-free 3D Cell Cultures
Others

Organoids

Intestinal Organoid
Neural Organoid
Pancreatic Organoid
Others

Request for covid19 Impact Analysis:

https://www.transparencymarketresearch.com/sample/sample.php?flag=c...

Global Laboratory Animal Models, 3D Cultures, and Organoids Market, by Application

Drug Discovery
Cancer Research
Personalized Medicine
Regenerative Medicines & Transplantations
Others

Global Laboratory Animal Models, 3D Cultures, and Organoids Market, by End-user

Life Sciences Companies
Academic & Research Institutes
CROs
Others

Global Laboratory Animal Models, 3D Cultures, and Organoids Market, by Region

North America

S.
Canada
Europe

Germany
K.
France
Italy
Spain
Rest of Europe

Asia Pacific

China
India
Japan
Australia & New Zealand
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. 

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement. 

Contact 

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com